Cost of Managing Type 2 Diabetes Before and After Initiating Dipeptidyl Peptidase 4 Inhibitor Treatment: A Longitudinal Study Using a French Public Health Insurance Database.
Corinne EmeryElodie TorretonSylvie DejagerLaurie Levy-BachelotSébastien BineauBruno DetournayPublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2020)
Despite an initial increase in healthcare expenditure, concomitant with reevaluation of patient care, this study showed that initiation of DPP4Is as an add-on therapy in French patients with T2D was associated with care expenditure that was in line or below predicted values within the 3 years following treatment initiation. Additional studies are required to evaluate the economic impact of the long-term treatment benefits.